Literature DB >> 34309530

Considerations on SARS-Cov-2 vaccines in patients with autoimmune blistering diseases.

Emanuele Cozzani1, Giulia Gasparini2, Laura Sticchi3, Roberto Russo1, Giancarlo Icardi3, Aurora Parodi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34309530     DOI： 10.1684/ejd.2021.4043

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  3 in total

1.  Considerations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Report.

Authors:  Denise Miyamoto; Claudia Giuli Santi; Celina Wakisaka Maruta; Valeria Aoki
Journal:  Front Med (Lausanne)       Date:  2022-04-12

2.  Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset.

Authors:  Roberto Russo; Giulia Gasparini; Emanuele Cozzani; Federica D'Agostino; Aurora Parodi
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

3.  COVID-19 severity and SARS-Cov-2 vaccine safety in pemphigus patients.

Authors:  Züleyha Özgen; Hasan Aksoy; Özlem Akın Çakıcı; Ayşe Esra Koku Aksu; Ozan Erdem; Asude Kara Polat; Mehmet Salih Gürel
Journal:  Dermatol Ther       Date:  2022-03-10       Impact factor: 3.858
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.